Welcome to our dedicated page for FULLER H B CO SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
H.B. Fuller Company filings document formal disclosures for a Minnesota-based public company that manufactures and sells adhesives, sealants and chemical-based products. Current reports furnish quarterly and fiscal-year operating results, including revenue, margin, adjusted EBITDA and guidance disclosures tied to pricing, raw-material costs, restructuring savings and acquisition or divestiture effects.
Proxy and governance filings cover annual meeting matters, director elections, auditor ratification, advisory executive-compensation votes, board committee service and director compensation arrangements. The filing record also includes exhibits and Inline XBRL cover data associated with material-event reports.
FULLER H B CO director Daniel L Florness reported a grant of 2,894.7400 Stock Units at $57.0000 per unit, each convertible into one share of common stock. These deferred units generally convert upon retirement, death, disability or certain specified events under the Directors' Deferred Compensation Plan, and include amounts from a dividend equivalent feature. Following the award, he holds 33,090.8600 stock units and 1351.0000 common shares directly.
Dimensional Fund Advisors LP, a Delaware limited partnership and registered investment adviser, reported beneficial ownership for Section 13(d) purposes of 2,857,738 shares of HB Fuller Co common stock, representing 5.3% of the class. Dimensional has sole voting power over 2,801,035 shares and sole dispositive power over 2,857,738 shares, with no shared voting or dispositive authority. All reported shares are held in client funds and accounts for which Dimensional or its subsidiaries provide investment management or advisory services, and those funds have the right to receive dividends and sale proceeds. Dimensional states that it may be deemed the beneficial owner of these shares through its advisory role but expressly disclaims beneficial ownership other than as may be deemed under Section 13(d) of the Securities Exchange Act of 1934.
FULLER H B CO senior vice president Joao Magalhaes reported a Form 4 showing an option exercise and his equity holdings. He exercised an employee stock option to acquire 1,658 shares of common stock at $50.10 per share, resulting in 5,523 common shares held directly after the transaction. The filing also lists multiple outstanding stock options and restricted stock units over common stock with various exercise prices and expiration dates, many vesting in three annual installments of 33%, 33%, and 34% and converting into common stock on a 1-for-1 basis, with some RSU amounts including dividend equivalent reinvestments.
Corkrean John J reported acquisition or exercise transactions in this Form 4 filing.
H.B. Fuller Executive VP and CFO John J. Corkrean reported a compensation-related award of phantom stock units linked to the company’s common shares. He received 215.85 phantom units at a reference price of $58.39 per unit, each convertible into one share of common stock.
After this grant, Corkrean holds 34,639.58 phantom units in total. The filing also shows direct ownership of 59,508 shares of common stock and multiple outstanding stock option and restricted stock unit awards, reflecting a substantial portion of his compensation tied to H.B. Fuller’s equity performance.
H.B. Fuller senior vice president Heather Campe reported updated equity holdings, including a compensation-related grant of 38.1500 Phantom Units tied to common stock at $58.3900 per unit. After this award, she directly holds 24,653.0782 shares of common stock and 5,776.5400 Phantom Units.
Campe also retains multiple restricted stock units and employee stock options on H.B. Fuller common stock. The options carry exercise prices between $51.8900 and $77.7200 per share with expiration dates ranging from 2028 to 2036. The restricted stock units and Phantom Units generally convert into common shares on a 1-for-1 basis, with some positions benefiting from dividend reinvestment and dividend equivalent features.
H.B. Fuller Company announced a recommended cash offer to acquire UK-based Advanced Medical Solutions Group plc (AMS), valuing AMS at an enterprise value of £715 million. Eligible AMS shareholders will receive £2.85 in cash for each AMS share, via a court-sanctioned scheme of arrangement under UK law.
The deal targets high-growth medical markets and is expected to deliver approximately $55 million (about £41 million) in combined run-rate revenue and cost synergies by 2031, supporting H.B. Fuller’s path to an EBITDA margin above 20%. To fund the transaction and related needs, the company secured a $2,086,713,188 secured bridge credit facility and a $917,000,000 unsecured bridge facility.
The transaction requires AMS shareholder approval, UK court sanction, regulatory clearances and the scheme becoming effective by June 25, 2027, with completion expected by the end of 2026. H.B. Fuller plans to deleverage to a net leverage target of 2.5x to 3x within two years after closing.
H.B. Fuller reported stronger results for the quarter ended May 30, 2026, with net revenue of $950.3 million, up 5.8% from a year earlier, driven mainly by higher pricing and favorable currency.
Gross margin improved to 33.6%, and net income attributable to H.B. Fuller rose to $67.8 million, or $1.23 diluted EPS, versus $0.76 a year ago. Adjusted EBITDA increased 9.3% to $181.0 million. For the first six months, revenue grew 2.0% to $1.72 billion and diluted EPS reached $1.61.
After quarter-end, the company agreed to a recommended cash offer for Advanced Medical Solutions Group plc valuing its share capital at approximately 659,000 British pounds and implying an enterprise value of about 715,000 British pounds. To support the deal, H.B. Fuller arranged bridge credit facilities totaling up to $3.0 billion.
H.B. Fuller reported a stronger second quarter of fiscal 2026, with net revenue of $950 million, up 5.8% from the prior year. Pricing added 3.0% to sales, more than offsetting slightly lower volumes and delivering 2.6% organic revenue growth.
Gross profit rose to $320 million, and adjusted gross margin expanded 200 basis points to 34.2%, helped by pricing execution and restructuring savings. Net income attributable to H.B. Fuller increased to $68 million, with diluted EPS of $1.23. Adjusted EPS reached $1.41, up 19% year-on-year.
Adjusted EBITDA was $181 million, up 9%, while net debt fell to $1.96 billion, reducing net debt-to-adjusted EBITDA to 3.1x. The company generated record second quarter operating cash flow of $121 million and repurchased 750 thousand shares. Based on year-to-date performance, management increased the midpoint of its full-year adjusted EBITDA and adjusted EPS guidance.
FULLER H B CO Executive VP and CFO John J. Corkrean reported updated equity holdings, including a new grant of Phantom Units. He received 195.98 Phantom Units at a reference value of $64.31 per unit, increasing his Phantom Unit balance to 34,423.73 units.
Corkrean also directly holds 59,508 shares of common stock, along with multiple tranches of restricted stock units and employee stock options that are tied to future vesting and expiration dates. The filing shows one compensation-related acquisition and no open-market purchases or sales of FULLER H B CO stock.
H.B. Fuller senior vice president of international growth Heather Campe reported mainly updated holdings, along with a small compensation-related grant. She received 34.640 Phantom Units, which are derivative awards tied to the company’s common stock, valued at $64.31 per unit.
After this grant, she directly holds 24,653.0782 shares of common stock and 5,738.3900 Phantom Units, plus multiple restricted stock unit and stock option awards with exercise prices ranging from $51.89 to $77.72 and expirations between 2028 and 2036. The filing reflects routine equity compensation and position reporting rather than open-market buying or selling.